Skip to main content

K Tanabe

First name:
K
Last name:
Tanabe
Ishihara, H. ., Takagi, T. ., Kondo, T. ., Tachibana, H. ., Yoshida, K. ., Omae, K. ., … Tanabe, K. . (2018). Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-018-1241-3 (Original work published 2018)
Matsuo, K. ., Tanabe, K. ., Ikeda, M. ., Shibata, T. ., Kajiwara, H. ., Miyazawa, M. ., … Mikami, M. . (2018). Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-018-4658-z (Original work published 2018)